Merck KGaA (XTER:MRK)
€ 154.5 -1 (-0.64%) Market Cap: 67.17 Bil Enterprise Value: 75.03 Bil PE Ratio: 23.96 PB Ratio: 2.53 GF Score: 90/100

Q4 2023 Merck KGaA Earnings Press Conference Transcript

Mar 07, 2024 / 09:00AM GMT
Release Date Price: €156.6 (-1.07%)
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the Fourth Quarter 2023. (Operator Instructions)

I'm now handing over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
Merck KGaA - Head of IR

Thank you very much, Heidi, and a very warm welcome to this Merck Full Year 2023 Results Call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck, and I'm delighted to be joined today by Belen Garijo, CEO of the group; as well as Helene von Roeder, CFO of the group. Also for the Q&A part of this call will be joined by Matthias Heinzel, CEO, Life Science; Peter Guenter, CEO of Healthcare; as well as Kai Beckmann, CEO of Electronics.

In the next couple of minutes, we would like to run you through the key slides of this presentation. And after that, we are happy to take all of your questions in the Q&A.

With this, I'd like to directly hand over to Belen to kick off the presentation. Over to you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot